| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.1 | 0.6 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.6 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |